Contemporary Management of Severely Calcified Coronary Lesions

Natthapon Angsubhakorn1, Nicolas Kang2, Colleen Fearon1

  • 1Division of Cardiology, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.

Insights

Coronary artery calcification poses challenges for percutaneous coronary intervention and increases cardiovascular event risk. This review details plaque modification techniques and emphasizes intravascular imaging for tailored treatment strategies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Coronary artery calcification (CAC) is a growing clinical concern.
  • Severe CAC impedes percutaneous coronary intervention (PCI) success.
  • CAC is linked to increased short-term and long-term adverse cardiovascular events.

Purpose of the Study:

  • To review current modalities for modifying calcified coronary plaque.
  • To compare the advantages and disadvantages of different plaque modification techniques.
  • To highlight the role of intravascular imaging in guiding calcium modification therapy.

Main Methods:

  • Review of existing literature on coronary calcium modification techniques.
  • Discussion of balloon angioplasty, coronary atheroablation (rotational, orbital, laser), and intravascular lithotripsy.
  • Emphasis on the utility of intravascular imaging for lesion characterization.

Main Results:

  • Various techniques exist for modifying calcified coronary lesions.
  • Each modality offers distinct benefits and drawbacks.
  • Intravascular imaging is crucial for assessing calcification severity and morphology.

Conclusions:

  • Tailoring calcium modification therapy based on lesion characteristics is essential.
  • Intravascular imaging aids in selecting the optimal treatment strategy.
  • Effective management of CAC improves PCI outcomes and reduces cardiovascular event risk.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
16
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27